uce
ProgressImage ProgressImage
Divis Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code 532488 border-img ISIN Demat INE361B01024 border-img Book Value 561.09 border-img NSE Symbol DIVISLAB border-img Div & Yield % 0.43 border-img Market Cap ( Cr.) 183267.56 border-img P/E 82.97 border-img EPS 83.21 border-img Face Value 2
Quarters
ParticularsMar 2025
()
Dec 2024
()
Sep 2024
()
Gross Sales2536.002297.002302.00
Other Operating Income0.000.000.00
Other Income 87.0082.00105.00
Total Income2623.002379.002407.00
Total Expenditure 1655.001550.001573.00
PBIDT968.00829.00834.00
Interest 0.000.001.00
PBDT968.00829.00833.00
Depreciation107.0099.0098.00
Tax225.00172.00218.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-31.00-36.00-1.00
Reported Profit After Tax667.00594.00518.00
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item667.00594.00518.00
    
EPS (Unit Curr.)25.1222.3919.51
EPS (Adj) (Unit Curr.)25.1222.3919.51
Calculated EPS (Unit Curr.)25.1722.4219.55
Calculated EPS (Adj) (Unit Curr.)25.1722.4219.55
Calculated EPS (Ann.) (Unit Curr.)100.6889.6678.19
Calculated EPS (Adj) (Ann.) (Unit Curr.)100.6889.6678.19
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity53.0053.0053.00
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)38.1736.0936.23
PBDTM(%)38.1736.0936.19
PATM(%)26.3025.8622.50
x
x
×
Let's Chat
close
refresh